Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.2 USD | -1.11% | -0.39% | -5.24% |
Business Summary
Number of employees: 112
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Respiratory Products
100.0
%
| 331 | 100.0 % | 310 | 100.0 % | -6.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 331 | 100.0 % | 310 | 100.0 % | -6.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 19/05/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 20/08/23 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 30/09/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 11/02/18 | |
Director/Board Member | 53 | 31/12/22 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 11/02/18 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 18/12/17 |
Mark Dipaolo
CHM | Chairman | 53 | 11/02/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 94,523,460 | 61,929,875 ( 65.52 %) | 32,005,000 ( 33.86 %) | 65.52 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ARMATA PHARMACEUTICALS, INC. 69.37% | 25,076,769 | 69.37% | 104,820,894 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-5.24% | 950M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- INVA Stock
- Company Innoviva, Inc.